CNN —

The latest results from a trial of a pill form of popular GLP-1 medications offer enough information for Eli Lilly to request global regulatory approval this year, the company said Tuesday.

Lilly, which makes the injectable drugs Zepbound to treat obesity and Mounjaro and Trulicity to treat diabetes, is among several companies chasing an effective pill form of such GLP-1 receptor agonists. In May , the US Food and Drug Administration accepted Novo Nordisk's marketing application for an oral version of its weight-loss drug Wegovy, with a decision expected toward the end of the year.

The only semaglutide pill that's currently available, Rybelsus , treats type 2 diabetes and comes with diet restrictions that are not necessary with Lilly's pill. To work best, Rybelsus need

See Full Page